NecstGen

The Netherlands Center for the Clinical advancement of Cell and Gene Therapies (NecstGen), situated in Leiden, comprises of a state-of-the-art facility and expert knowledge for the development, production, and commercialization of Cell and Gene Therapies. NecstGen helps academic and industrial Cell & Gene Therapy developers to enter the clinical stage by bringing together the required expertise from R&D, development, production, QA, QC and regulatory affairs in a brand new 4,000 m2 development & GMP manufacturing facility. We enable the next generation of therapies by translating research programs into actionalbe health solutions for patients. Our service offering: A flexible Cell and...

Gmp,cell therapy,gene therapy,viral vector production,ipsc,esc,process development,regenerative medicine,atmp,viral vector,lentivirus,aav,oncolytic virus,cleanroom rental,msc,car-t,til,nk,and dc

Necstgen operates in the Pharmaceutical manufacturing industry.

Necstgen's revenue is 11m - 100m

Necstgen has 11 - 50 employees.